Low tumour-infiltrating lymphocyte density in primary and recurrent glioblastoma

Immunotherapies targeting tumour-infiltrating lymphocytes (TILs) that express the immune checkpoint molecule programmed cell death-1 (PD-1) have shown promise in preclinical glioblastoma models but have had limited success in clinical trials. To assess when glioblastoma is most likely to benefit fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Maddison, Kelsey, Graves, Moira C., Bowden, Nikola A., Fay, Michael, Vilain, Ricardo E., Faulkner, Sam, Tooney, Paul A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522837/
https://www.ncbi.nlm.nih.gov/pubmed/34676050
http://dx.doi.org/10.18632/oncotarget.28069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522837/
https://www.ncbi.nlm.nih.gov/pubmed/34676050
http://dx.doi.org/10.18632/oncotarget.28069

Ejemplares similares